NEWS CENTER

Quality is the brand; quality is the growth driver!

Publish Time:

2026-07-23

Keyuan Pharmaceutical has launched a special campaign titled “Quality Assurance: 100-Day Intensive Effort”!

Keyuan Pharmaceutical launches the “Quality Assurance, 100-Day Intensive Effort” special campaign!

To further strengthen the foundation of quality management, fortify the defense line for product quality, and comprehensively enhance product quality and core market competitiveness, Keyuan Pharmaceutical held a grand launch conference on July 23 for its “Quality Guardianship: 100-Day Intensive Effort” special campaign. The company’s management team, heads of all departments, and all frontline production and quality‑control personnel attended, officially kicking off this 100‑day initiative to elevate product quality.

Quality is the cornerstone of Keyuan Pharmaceutical and the foundation of its development. For many years, Keyuan Pharmaceutical has steadfastly upheld the principle of “quality first, pursuit of excellence,” regarding product quality as the lifeline of the company’s growth and continuously building and refining a market‑oriented, internationally aligned, end-to-end quality management system.

Backed by a rigorous quality‑control system and superior product quality, the company’s core products have successfully obtained official pharmaceutical approvals from multiple regulatory authorities, including China’s National GMP, the U.S. FDA, the EU’s EDQM, South Korea’s MFDS, and Japan’s PMDA. This has earned widespread recognition in global markets for the company’s advanced quality‑management standards and the credibility of its products, laying a solid foundation for deepening its presence in international markets and expanding its global footprint.

Quality assurance is an ongoing journey. In response to evolving market demands and the company’s own internal drive for high‑quality development, Keyuan Pharmaceutical has proactively raised its standards and set new benchmarks. Across the entire organization, it has launched a special “Quality Assurance: 100‑Day Intensive Effort” campaign, employing a focused, 100‑day initiative to comprehensively identify quality risks, address management gaps, and strengthen the foundation of quality, thereby elevating the company’s quality management to a new level.

At the kickoff meeting, to strengthen hierarchical accountability and refine the division of control responsibilities, quality‑management entities at all levels of the company signed quality‑responsibility agreements, clearly defining the duties, performance‑evaluation criteria, and reward‑and‑penalty mechanisms for each position and each stage of the process. This established a quality‑management accountability system characterized by “layered responsibility, individual accountability, and end‑to‑end controllability,” thereby fully bridging the “last mile” in implementing quality‑control measures.

This special campaign will run for 100 days, featuring a comprehensive scope, broad coverage, and targeted measures, encompassing multiple core work units. During the campaign, the company will conduct regular, company-wide self-inspections to thoroughly identify potential quality risks in production, control processes, and workflows; organize company‑wide quality knowledge competitions and specialized training programs to promote adherence to quality standards, enhance job‑specific skills, and strengthen quality awareness across all levels; concurrently launch a lean‑management initiative for quality improvement, encouraging all employees to proactively offer suggestions and drive innovation; and reinforce day‑to‑day quality oversight and management throughout the entire production process, refining inspection, sampling, and re‑inspection procedures to ensure early detection, prompt corrective action, and zero omissions in addressing quality issues.

The launch of this special campaign represents a key initiative by Keyuan Pharmaceutical to deepen its commitment to quality, advance refined management, and achieve high‑quality development. All responsible parties have pledged to seize this 100‑day intensive effort as an opportunity to continuously refine the company’s quality management system, foster a culture of uncompromising quality across the organization, and drive improvement through dedicated execution. By doing so, they aim to establish a benchmark for premium‑quality products and support the company’s long‑term, sustainable growth.

None

The Chairman of Keyuan Pharmaceutical was invited to attend the Third Global Go‑Global Summit, where they jointly explored new pathways for the pharmaceutical industry’s international expansion.

None

The Chairman of Keyuan Pharmaceutical was invited to attend the Third Global Go‑Global Summit, where they jointly explored new pathways for the pharmaceutical industry’s international expansion.